Department of Urology Archives
Study reveals pathways for aggressive prostate cancer subtype
Oct. 27, 2022—Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.
Gender differences with bladder pain
Sep. 26, 2022—Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.
Study describes how E. coli co-opts cells, causes recurrent UTIs
Aug. 25, 2022—Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.
Clinic helps patients prepare to move beyond prostate cancer
Aug. 4, 2022—Vanderbilt's REACH for Survivorship Clinic takes a holistic approach to help treat prostate cancer patients.
Female bladder cancer patients to benefit from new care support coordinator
Aug. 4, 2022—A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center.
New Clinician Spotlight: Jeffrey Tosoian
Mar. 11, 2022—Jeffrey Tosoian, MD, MPH, joined the Department of Urology at Vanderbilt University Medical Center recently after completing his fellowship at the University of Michigan.
Prostate cancer treatment regret
Dec. 9, 2021—Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity.
Program extends palliative care knowledge to improve patient care
Nov. 18, 2021—A new resource at Vanderbilt is helping medical students, residents and even long-standing medical faculty to enhance their palliative care skills.
Combo therapy slows prostate cancer
Oct. 19, 2021—A new combination treatment showed promise in slowing the growth of castration-resistant prostate cancer in animal models, Vanderbilt researchers discovered.
Stimson named CMO of Employee Health Plans
Aug. 4, 2021—C.J. Stimson, MD, JD, assistant professor of Urology at Vanderbilt University Medical Center, has been named Chief Medical Officer (CMO) of the VUMC and Vanderbilt University Employee Health Plans.
Treating metastatic prostate cancer
Jun. 22, 2021—An indirect comparative effectiveness study using published data suggests that the targeted therapy olaparib should be re-evaluated for treating metastatic prostate cancer.
Rodes and Patricia Hart establish second chair in Department of Urology
Apr. 14, 2021—H. Rodes Hart, BA’54, and Patricia Ingram Hart, BA’57, whose generous gifts continue to advance the mission of Vanderbilt as one of the world’s great universities for learning and discovery, have endowed a second chair in Urologic Surgery.
